Neoanthem Lifesciences Private Limited, a active private limited company, was established on 22 July 2020 in Bengaluru, Karnataka, India. Engaging in biotechnology within the manufacturing sector, it holds CIN: U24239KA2020PTC136337. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹150.00 Cr and a paid-up capital of ₹100.15 Cr.
Its leadership includes Ganesh Sambasivam (Director), Ajay Bhardwaj (Director), K Ravindra Chandrappa (Director). It holds ₹214.00 Cr open charges and ₹214.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No. 49, F1 & F2, Canara Bank Road Bommasandra Industrial Area, Bengaluru, Karnataka, 560099.
U24239KA2020PTC136337
136337
22 July 2020
₹150.00 Cr
₹100.15 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Neoanthem Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ganesh Sambasivam | Director | 22 Jul 2020 | Current |
| Ajay Bhardwaj | Director | 22 Jul 2020 | Current |
| K Ravindra Chandrappa | Director | 22 Jul 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Neoanthem Lifesciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 155.01%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
In 2023, Neoanthem Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,140,000,000.00
₹2,140,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Jun 2022 | Others | ₹214.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Neoanthem Lifesciences has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Neoanthem Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neoanthem Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 01 Jun 2022 via Charge ID 100585477 with Others was fully satisfied on 02 Jun 2025. was completed.
The activity Neoanthem Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Neoanthem Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was completed.
The activity A charge with Others amounted to Rs. 214.00 Cr with Charge ID 100585477 was registered on 01 Jun 2022. was completed.
Ganesh Sambasivam was appointed as a Director was appointed as a Director on 22 Jul 2020 & has been associated with this company since 5 years 4 months . was recorded as a recent event.
Ajay Bhardwaj was appointed as a Director was appointed as a Director on 22 Jul 2020 & has been associated with this company since 5 years 4 months . was recorded as a recent event.
The CIN of Neoanthem Lifesciences Private Limited is U24239KA2020PTC136337.
Neoanthem Lifesciences Private Limited is headquartered at No. 49, F1 & F2, Canara Bank Road Bommasandra Industrial Area, Bengaluru, Karnataka, 560099.
Neoanthem Lifesciences Private Limited was incorporated on 22 July 2020.
The current directors of Neoanthem Lifesciences Private Limited are
The primary industry of Neoanthem Lifesciences Private Limited is Manufacturing.
Neoanthem Lifesciences Private Limited is unlisted.
The authorized capital of Neoanthem Lifesciences Private Limited is ₹150.00 Cr, and the paid-up capital is ₹100.15 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX